Literature DB >> 11327232

Delayed life-threatening reaction to anthrax vaccine.

B Swanson-Biearman1, E P Krenzelok.   

Abstract

BACKGROUND: Anthrax is an acute infectious disease caused by the spore-forming bacterium Bacillus anthracis. Due to the current world threat of unpredictable biological terrorism, the Department of Defense has mandated the systematic vaccination of all US military personnel against this warfare agent. Many may experience al mild flu-like illness and soreness at the injection site, but systemic reactions are rare. CASE REPORT: We report a delayed and potentially serious life-threatening adverse reaction to anthrax vaccine. A previously healthy 34-year-old male was transported to the emergency department with dyspnea, diaphoresis, pallor, and urticarial wheals on his face, arms, and torso after the administration of the third dose of anthrax vaccine. All symptoms resolved after pharmacological intervention and the patient was discharged. Pharmaco-epidemiological data indicate that 30% of anthrax vaccine recipients experience mild local reactions. With large numbers of military personnel being vaccinated, emergency physicians may encounter more vaccine-related adverse reactions.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11327232     DOI: 10.1081/clt-100102885

Source DB:  PubMed          Journal:  J Toxicol Clin Toxicol        ISSN: 0731-3810


  5 in total

1.  Human antibodies against spores of the genus Bacillus: a model study for detection of and protection against anthrax and the bioterrorist threat.

Authors:  Bin Zhou; Peter Wirsching; Kim D Janda
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-16       Impact factor: 11.205

2.  Neutralizing activity of vaccine-induced antibodies to two Bacillus anthracis toxin components, lethal factor and edema factor.

Authors:  Sarah C Taft; Alison A Weiss
Journal:  Clin Vaccine Immunol       Date:  2007-11-21

3.  Toxicity of anthrax toxin is influenced by receptor expression.

Authors:  Sarah C Taft; Alison A Weiss
Journal:  Clin Vaccine Immunol       Date:  2008-07-02

Review 4.  Anthrax vaccination strategies.

Authors:  Robert J Cybulski; Patrick Sanz; Alison D O'Brien
Journal:  Mol Aspects Med       Date:  2009-09-01

Review 5.  A genomics-based approach to biodefence preparedness.

Authors:  Claire M Fraser
Journal:  Nat Rev Genet       Date:  2004-01       Impact factor: 53.242

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.